Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-01-27
1997-08-12
Stone, Jacqueline M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424563, 424570, 424520, 514 44, 604 49, C12N 1500, A61K 3530, A61K 4800, A61F 266
Patent
active
056562675
ABSTRACT:
This invention provides a method of alleviating chronic pain in humans. Viable, implantable cells are selected which release neuroactive substances that reduce chronic pain. The cells are cultured to improve their viability, and administered into a region of the central nervous system of a patient who is suffering from chronic pain. The cells continue to secrete the neuroactive substances within the patient without exogenous stimulation. Suitable implantable cells include adrenal medullary tissue cells, chromaffin cells or genetically engineered cells.
REFERENCES:
patent: 4753635 (1988-06-01), Sagen et al.
----Pain, Supplement 3, 1986. "Pain, " The Intl. Assoc. for the Study of Pain. pp. S3-S4.
Aerbischer, et al., Abstract Cell Transplant. 3(3):229 (1994).
Andrews, P.W. Dev. Biol. 103: 285-293 (1984), copy attached as Exhibit 22 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Bonica, J., Chapter 8, The management of Pain, eds. Chapman & Fortis, Lea & Fibiger pp. 180-191 (1990).
Comb, et al., EMBO J. 4(12): 3115-3122 (1985) (copy attached as Exhibit 19 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Cullen, B.R., "Use of eukaryotic expression technology in the functional analysis of cloned genes", pp. 684-704 in Berger, S.L. & Kimmel, A.R., Guide to Molecular Cloning Techniques, Academic Press, New York (1987) (attached as Exhibit 18 to Amendment and Response under Rule 111 filed Jun.20, 1996).
Czech et al., Prog. Neurobiology 46: 507-529 (1995) (copy attached as Exhibit 28 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Flaris et al., Lab Invest. 62(4): 493-497 (Apr. 1990).
Maniatis et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor (1982), (pp. i-x attached as Exhibit 16 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Lazorthes, Y., et al., Acta Neurochir. [Suppl. ] 64:97-100 (1995) (copy attached as Exhibit 31 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Lundberg et al., Pro. Nat. Acad. Sci. USA 76(8):4079-4083 (Aug. 1979).
Noel, G. et al., J. Neurochemistry, 52: 1050-1057 (1989) (copy attached as Exhibit 23 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Orrison, W.W., Jr., Introduction to Neuroimaging, Little-Brown, Boston (1989) pp. 293-313, copy attached as Exhibit 26 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Ortega et al., Abstract, III Intl Symp. on Neural Transplant. p. 26 (198?).
Pappas et al., Abstract. Fifth Intl. Symp. on Chromaffin Cell Biol. p. 60 (1989 ).
Sagen et al., Ann. N.Y. Acad. Sci. 495:306-333 (1987).
Pappas et al., Abstract, III INtl Symp. on Neural Transplant. p. 25 (198?).
Sagen et al., Experimental Neurology 102: 290-297 (1988) (copy attached as Exhibit 24 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Sagen et al., Abstract. Fifth Intl Symp. on Chromaffin Cell Biol. p. 115 (1989).
Sagen, et al., Abstract 51.
Sagen et al., Cell Transplantation 2: 259-266 (1993) (copy attached as Exhibit 30 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Sagen et al., Brain Res. 502: 1-10 (1989).
Sagen et al., Pain 42: 69-79 (1990).
Sambrook et al., Molecular Cloning. A Laboratory Manual 2d, Cold Spring Harbor (1989) (pp. 16.2-16.36 attached as Exhibit 17 to Amendment and Response under Rule 111 filed Jun.20, 1996).
Sardet, C. et al., Cell 56:271-280 (1989) (copy attached as Exhibit 20 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Unsicker, K., Experimental Neurology, 123: 167-173 (1993) (copy attached as Exhibit 32 to Amendment and Response under Rule 111 filed 20, 1996).
Unsicker, et al., Int. J. Devl. Neuroscience, 10: 171-179 (1992) (copy attached as Exhibit 33 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Vaquero et al., The Lancet, 1315 (1988) (copy attached as Exhibit 9 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Wang, et al., Abstract, Soc. Neurosci. 14:1005 (1988).
Winnie et al., Anesthesiology 79: 644-653 (1993) (copy attached as Exhibit 29 to Amendment and Response under Rule 111 filed Jun. 20, 1996).
Yaksh, T.L. The central pharmacology of Pain States in Basic Mechanisms of Pain and Pain Control .
Sagen et al., Ann. N.Y. Acad. Sci., 495, 1987, 306-333.
Vaquero et al., The Lancet, Dec. 3, 1988, 1315.
Czech et al., Prog. Neurobiology, vol. 46, 1995, 507-529.
Pappas George Demetrios
Sagen Jacqueline
Milne Andrew
Stone Jacqueline M.
LandOfFree
Implantable cells that alleviate chronic pain in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable cells that alleviate chronic pain in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable cells that alleviate chronic pain in humans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-158085